Delivery Order SPE2DE21D7009-SPE2D626F45N5
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $49,861.17 on July 14, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of July 25, 2025, and will be performed in Valencia, California. The contract carries no set-aside designation, indicating open competition in the federal marketplace. The funding agency is the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $36,589.22 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 19, 2025, and is being performed in Valencia, California. The award carries no set-aside designation, indicating open competition in the federal marketplace. The contract is funded through the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $1,825.75 on November 28, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment authority is performance-based in Valencia, California, and carries an ultimate completion date of December 5, 2025. The contract was awarded by the Medical Supply Chain, a defense-related procurement entity under the Department of...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $31,771.22 fixed-price delivery order (Contract No. 4570331497) on December 15, 2025, for pain management medical devices and related services. The award carries an economic price adjustment clause and is scheduled for completion by December 29, 2025. This delivery order was issued under the company's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,798.00 on November 28, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of December 5, 2025 and will be performed in Valencia, California. The award was issued by the Medical Supply Chain, a Defense-related procurement entity within the federal government, with no small...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $41,406.68 fixed-price delivery order with economic price adjustment for pain management medical devices and services. The award, issued on September 9, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation and will be performed in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a fixed-price delivery order valued at $43,709.82 on December 15, 2025, for pain management medical devices and equipment. The delivery order, with a ultimate completion date of December 22, 2025, will be performed in Valencia, California, and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-related procurement entity within the Department of Defense. This award carries no small...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $1,867.00 fixed-price delivery order with economic price adjustment on November 28, 2025, for pain management medical devices and services. The contract, identified as PAIN MANAGEMENT (4570238376), is set to be completed by December 5, 2025, with performance occurring in Valencia, California. This delivery order was funded by the Medical Supply Chain, a defense-related procurement entity, and represents...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $42,456.67 on November 28, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment provisions falls under the larger Defense Logistics Agency Troop Support Medical indefinite delivery contract (SPE2DE) valued at $83.1 million and running through August 16, 2026. The award carries no small business set-aside...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F45N5Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $36,654.68 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of December 29, 2025 and will be performed in Valencia, California. The award is issued under a larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical branch, valued at $83.1 million through August 16, 2026. No small business set-aside was used for this award, allowing Boston Scientific Neuromodulation to compete on an unrestricted basis. The contract supports the Department of Defense's non-opioid pain management initiatives by providing advanced neuromodulation technologies, including spinal cord stimulation systems, implantable pain pumps, and associated accessories to military treatment facilities and Veterans Affairs medical centers nationwide. The funding source is the Medical Supply Chain, a defense-related procurement entity within the Department of Defense. Boston Scientific Neuromodulation Corp specializes in delivering sophisticated medical devices and technical support services focused on chronic pain management for service members and veterans, with particular emphasis on alternatives to opioid-based pain management. The company's core product portfolio includes proprietary technologies such as RestoreSensor and Spectra WaveWriter spinal cord stimulators, along with training, data management, and comprehensive technical support services that enable sustained pain management capabilities across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.7k | 12/14/25 |